BSX FY 2021 Earnings — Boston Scientific Corporation Revenue & Financial Results | Market Cap Arena

BSXBoston Scientific Corporation

$105B

FY 2021 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$11.9B+19.9% YoY

Gross Profit

$7.5B62.8% margin

Operating Income

$1.9B16.2% margin

Net Income

$1.0B8.7% margin

EPS (Diluted)

$0.69

Cash Flow

Operating Cash Flow

$1.9B

Free Cash Flow

$1.3B

Stock-Based Comp.

$194M

Balance Sheet

Total Assets

$32.2B

Total Liabilities

$15.6B

Stockholders' Equity

$16.6B

Cash & Equivalents

$1.9B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$11.9B	$9.9B	+19.9%
Gross Profit	$7.5B	$5.6B	+33.8%
Operating Income	$1.9B	$601M	+219.8%
Net Income	$1.0B	-$82M	+1368.3%